CSPC Pharmaceutical Group (HK:1093) has released an update.
CSPC Pharmaceutical Group Limited has announced the on-market purchase of 7 million shares under its restricted share award scheme, at an average price of HK$6.887 per share, totaling approximately HK$48.205 million. The shares, which represent about 0.059% of the total issued shares, are held in trust for selected participants. The company’s board will continue to evaluate and decide on the awarding of shares and future market purchases.
For further insights into HK:1093 stock, check out TipRanks’ Stock Analysis page.
